← Eichor
Study identifier: NCT06607588 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Selection of Resistant Mutations to Dolutegravir in PLWH Treated in Mozambique

Condition: HIV · HIV Antiretroviral Therapy (ART) Adherence  ·  Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia

PhaseN/A
Planned participants200
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The HIV infection not fully controlled, despite being under antiretroviral treatment, could make virus resistance against the antiretroviral treatments, making hardest the well control of HIV infection. The purpose of this research study is to confirm or deny if a not fully good controlled HIV infection could develop virus resistance against antiretroviral drugs that can difficult the good control of the HIV infection.

This description comes directly from the study's public registry record.

Talk to the study team

Daniel Podzamczer, PhD  ·  0034675335888  ·  dpodzamczer@gmail.com

Antonio Navarro, MSc  ·  +0034675335888  ·  anavarro@igtp.cat

Always discuss trial participation with your own doctor first.

Locations (1)

Hospital CarmeloChokwé, MozambiqueRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06607588